The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
The book “Science behind Suryanamaskar” has been compiled by the AIIA’s Department of Swasthavritta and Yoga.
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the OlympiA trial, in these patients
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of US $282 million in the US
The funding round also saw participation from some of India's top angel investors and leading industry giants
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
Subscribe To Our Newsletter & Stay Updated
